Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Preclinical efficacy of a humanized anti-CD20 monoclonal antibody against NHL

June 13, 2003

MedImmune and Micromet to codevelop MT-103

June 12, 2003

Positive interim data from phase II trial of Allovectin-7 reported at ASCO

June 12, 2003

Manufacturing of CoFactor underway

June 10, 2003

Interim findings from ongoing phase I trial of OncoVEX(GM-CSF)

June 6, 2003

HER-2/neu vaccine enters phase I trial for breast cancer

June 6, 2003

Oncofetal protein validated as a potential target for lung cancer immunotherapy

June 6, 2003

EMD-72000 shows good tolerability and evidence of antitumor activity in phase I trials

June 5, 2003

Orphan drug status awarded to KSB-303 for pancreatic cancer

May 30, 2003

Safety phase of lactoferrin study completed

May 27, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...